Crohn's Disease Supplements: What the Evidence Actually Shows – Agape Nutrition
Left Continue shopping
Your Order

You have no items in your cart

Editorial cream and forest green thumbnail reading Crohn's Supplements, what the evidence shows.

Crohn's Disease Supplements: What the Evidence Actually Shows

Crohn's disease is a chronic inflammatory bowel disease that relapses and remits. It can flare for months, quiet down, then return. No supplement changes that underlying course, and none replaces the medical therapy your gastroenterologist prescribes. Supplements can work as adjuncts: filling a measured nutrient gap, supporting bone or immune function, or supporting healthy digestion alongside treatment. This guide ranks options by human evidence and separates active disease from remission. Talk to your gastroenterologist before you start, stop, or change anything.

Most supplements sold for Crohn's lack trial evidence. Two of the most promoted, curcumin and fish oil, have negative pooled or large-trial results. The strongest evidence is not a capsule. It is food-based therapy. We graded each section by the size and quality of the human data. For a wider view, see our digestion and gut health resource page.

The short answer: what has the most evidence

Here is the ranked picture, strongest human evidence first.

  1. Food-first therapy. Exclusive enteral nutrition and the Crohn's Disease Exclusion Diet have the best trial base. Both are medical nutrition therapies, not shelf products.
  2. Testing and correcting deficiencies. Test vitamin D, B12, iron, zinc, calcium, and magnesium. Correct what is low.
  3. Boswellia. One positive active-disease trial, one failed maintenance trial. Possible in mild active disease, not maintenance.
  4. Curcumin. Strong in ulcerative colitis, but pooled Crohn's data show no superiority over placebo. Worth discussing, not worth expecting.
  5. Probiotics. Strain-specific and weak in Crohn's. Do not borrow evidence from ulcerative colitis or pouchitis.
  6. Omega-3. One small 1996 win, then two large trials and a Cochrane review showing no maintenance benefit.

The setting and the dose matter more than the label.

How we graded the evidence

Evidence ladder ranking Crohn's supplements from strongest to weakest human trial evidence.
Human evidence for Crohn's supplements runs from food-based therapy at the top to probiotics at the bottom.

A supplement trial is not a drug trial. Many Crohn's studies are small, single-center, and short, with different endpoints. Clinical remission means symptoms have settled. Endoscopic remission means the lining looks healed on a scope. A calprotectin drop is a lab marker, not a symptom score.

Most trials test the supplement alongside standard medicine, not instead of it, which makes it an add-on. A result can be statistically significant and still be small in real life. A 2022 review agrees: nutraceuticals in Crohn's are adjuncts, with limited evidence [17]. We ranked each section by the size and quality of the human evidence, and we flag where it is thin.

Food-first therapy: EEN and CDED

This is the strongest evidence in Crohn's, and most supplement pages skip it. Both are medical nutrition therapies, not bottle supplements, and both run through your care team.

Exclusive enteral nutrition (EEN)

EEN replaces all food with a liquid formula for a set period, usually 6 to 8 weeks. A 2026 meta-analysis pooled 40 studies and 2,459 adults with active Crohn's [1]. Real-world clinical remission was 66 percent (95 percent CI 0.60 to 0.71).

Steroids still beat it. Across 5 randomized trials and 315 adults, corticosteroids produced higher remission (risk ratio 0.65, 95 percent CI 0.50 to 0.84 favoring steroids) [1]. EEN works, but in adults steroids work better. Formula type did not matter: elemental and non-elemental formulas performed the same (risk ratio 1.04) [1]. In two studies, adding EEN to biologics beat biologics alone (risk ratio 0.75, 95 percent CI 0.67 to 0.84) [1].

A shelf-available elemental formula such as Integrative Therapeutics Physicians' Elemental Diet Powder is a nutritionally complete liquid formula, for use under medical supervision. It is not the formula used in the trials above, and it does not replace a supervised EEN protocol.

The Crohn's Disease Exclusion Diet (CDED)

CDED is a whole-food plan that removes specific foods and uses partial formula. A 2026 meta-analysis of 17 studies, 16 with pooled data, found pooled clinical remission of 69 percent at 6 to 8 weeks (95 percent CI 0.65 to 0.74) [2]. CDED beat EEN head to head (odds ratio 2.05, 95 percent CI 1.13 to 3.74) and beat steroids (odds ratio 17.33, 95 percent CI 1.75 to 171) [2]. Maintenance favored CDED (odds ratio 2.73, 95 percent CI 1.3 to 5.74). Endoscopic data are limited, so treat the symptom numbers with caution. CDED is promising, and it is best done with a dietitian. Our guide to the elemental diet explains how formula-based therapy works.

Partial enteral nutrition may also help at higher doses, though the evidence is weaker [3].

Two-column chart splitting Crohn's supplement evidence into active disease versus maintenance.
The same supplement can behave differently in active disease and in remission. This is the split the trials actually show.

Curcumin: strong in UC, not proven in Crohn's

Curcumin is the yellow compound in turmeric, and it has the deepest trial base in ulcerative colitis. Crohn's is a different disease.

What the pooled data show

A 2025 meta-analysis of 13 placebo-controlled trials in inflammatory bowel disease found curcumin effective for clinical remission and response in ulcerative colitis [4]. In Crohn's disease, curcumin did not show superiority over placebo for clinical or endoscopic remission [4]. Adverse events did not differ from placebo.

The small Crohn's trials

A 2022 review found only 2 Crohn's trials [5]. At least one showed improvement in a clinical outcome, but the numbers were small. Small positive trials against a negative pooled result are a reason to ask your GI, not a reason to buy. For the contrasting evidence, see our ulcerative colitis supplements guide.

Form and safety

Curcumin is poorly absorbed, so formulation matters. Trials used curcuminoid extracts, not culinary turmeric. Our curcumin benefits guide explains the delivery forms. Curcumin can add to bleeding risk when combined with blood thinners [19]. Ask your gastroenterologist before combining it with an anticoagulant or immunosuppressant.

Boswellia: possible in active disease, not for maintenance

Two boswellia trials point in different directions. Read together, they define a narrow role.

The active-disease trial

Gerhardt 2001 randomized 102 people with active Crohn's to a Boswellia serrata extract called H15 or to mesalamine [6]. The Crohn's Disease Activity Index fell 90 points with H15 and 53 points with mesalamine. Non-inferiority was confirmed, and H15 was well tolerated with a better benefit-risk profile. The trial was small, older, and analyzed 83 patients. That supports a possible role in mild active disease, for that specific extract.

The failed maintenance trial

Holtmeier 2011 enrolled 108 people in remission and randomized 82 to Boswelan, two 400 mg capsules three times daily, or placebo for 52 weeks [7]. Remission held in 59.9 percent of the active group and 55.3 percent of the placebo group. The trial stopped for futility, though safety was good [7]. Boswellia is not a maintenance therapy.

Omega-3: one old positive trial, two large negative ones

Fish oil is often sold for Crohn's maintenance. The evidence is one small win and two losses.

Belluzzi 1996

Belluzzi and colleagues gave 78 people in remission a specific enteric-coated fish oil at 2.7 g of omega-3 per day for 1 year [8]. Relapse occurred in 28 percent versus 69 percent, and 59 percent versus 26 percent stayed in remission (P = .003). That was a real result from one small trial and one specific preparation.

EPIC-1 and EPIC-2

Feagan 2008 ran EPIC-1 and EPIC-2 with 363 and 375 patients [9]. They used 4 g per day of omega-3 free fatty acids for up to 58 weeks. Relapse was 31.6 percent versus 35.7 percent in EPIC-1 and 47.8 percent versus 48.8 percent in EPIC-2. The large trials found no benefit.

The Cochrane view

A 2014 Cochrane review called omega-3 probably ineffective for Crohn's maintenance [10]. Parenteral omega-3 after surgery is hospital therapy, not a capsule [11]. Do not rely on fish oil as Crohn's maintenance. Our fish oil buying guide covers forms and dosing.

Probiotics: strain-specific and weak in Crohn's

The category is not the evidence. The strain is.

A 2025 review of human randomized trials calls probiotics a potential strategy [12]. The trials vary by strain and setting, so the product matters as much as the category. There is no strong Crohn's maintenance recommendation. Do not borrow the evidence from ulcerative colitis or pouchitis, where specific strains have real data. Our guide to choosing a probiotic explains how to read a label.

Vitamin D: test, correct, and protect bone

Vitamin D is one of the most studied micronutrients in Crohn's, and one of the most overclaimed. Test 25(OH)D, the standard blood test, rather than guessing.

A 2025 randomized trial in children with inflammatory bowel disease (IBD) compared daily 2,000 IU of vitamin D3 with a single high-dose stoss dose for correcting deficiency [14]. Current guidance is to supplement when 25(OH)D falls below 50 nmol/L. Correcting a deficiency is worthwhile. Expecting vitamin D to change disease activity is not supported. If your level is low, a chewable vitamin D3 5,000 IU is one option; set the dose with your clinician and retest. Bone health also matters, especially with corticosteroid use. Our vitamin D3 and K2 guide covers testing and safe dosing.

B12, iron, zinc, calcium, and magnesium: the deficiency checklist

A 2023 review of 42 studies in adults with Crohn's in clinical remission found low circulating vitamins A, B6, B12, C, beta-carotene, D, magnesium, selenium, and zinc [13]. Vitamin D and B12 were the most studied. Vitamin D was lower than controls in only one quarter of studies, so deficiency is common enough to test, not universal. Test, then correct the result.

  • Vitamin B12. Risk rises with disease or surgery in the terminal ileum, where B12 is absorbed. Ask for a level if you have had ileal surgery or long-standing ileal disease. If it is low, a methylcobalamin B12 chewable is one way to correct it.
  • Iron and ferritin. Iron deficiency anemia can affect up to 90 percent of people with IBD [15]. It should be treated, not accepted as normal. Test ferritin with CRP, because inflammation can mask low iron.
  • Zinc. Deficiency is common in Crohn's and is associated with worse outcomes [16]. Low zinc was linked to changes in tight junction proteins and higher IL-17. Test serum zinc and correct if low. If it is low, a zinc-carnosine supplement is one option.
  • Calcium and vitamin D. Bone loss is a real concern, especially with corticosteroids. Test and correct rather than megadose.
  • Magnesium. Losses can occur with chronic diarrhea. Review it with your care team.

These are correction targets, not Crohn's treatments. The foundation of care is the medical therapy that controls inflammation [18].

What to skip, and what not to expect

  • High-dose iron without a test. Excess iron can be harmful, and ferritin is unreliable during inflammation.
  • Unproven herbal immune boosters. Products sold for immune support or detox rarely have Crohn's trials and some interact with immunosuppressants.
  • Turmeric with blood thinners. Curcumin can add to bleeding risk when combined with antithrombotic therapy [19].
  • Insoluble fiber during a stricture. Bulky fiber can worsen obstruction symptoms.
  • Megadoses. More is not better without a deficiency.

No supplement is a rescue plan for a flare. Flare management belongs to your gastroenterologist.

What We Recommend

Dose card of Crohn's supplement trial doses, including EEN 66% and CDED 69% remission rates.
The doses and results the human trials used, from EEN and CDED to curcumin, boswellia, omega-3 and vitamin D.

These are adjuncts, not treatments. Each one matches a conclusion above, and none replaces your prescribed therapy. Test first where this guide says to test, and set the dose with your gastroenterologist or dietitian.

Integrative Therapeutics Physicians' Elemental Diet Powder is a shelf-available elemental formula, for use under medical supervision and not the trial formula. Price: $59.25 for the 432 g tub.

Integrative Therapeutics Vitamin D3 5,000 IU is a chewable cholecalciferol option for correcting a documented low 25(OH)D after testing. Price: $23.50.

DaVinci Labs Chewable B12-MC provides methylcobalamin B12 with folate for a low B12 level, especially with ileal disease or surgery. Price: $25.46.

Integrative Therapeutics Zinc-Carnosine supplies zinc-carnosine for correcting a low serum zinc; its GI-lining evidence is from other contexts, not Crohn's maintenance. Price: $38.50.

FAQ

What is the best supplement for Crohn's disease?

There is no single best supplement, because the evidence is modest and setting-specific. Food-based therapy has the strongest data, followed by testing and correcting deficiencies. Boswellia has one positive active-disease trial; curcumin and fish oil have negative pooled or large-trial results.

Can supplements replace Crohn's medication?

No. The trials tested supplements alongside standard medicine, not instead of it. None supports stopping or reducing your prescription.

Is curcumin good for Crohn's?

The pooled evidence says it is not superior to placebo in Crohn's [4]. It has strong data in ulcerative colitis, a different condition. Small Crohn's trials reported some improvement, but numbers were too small.

Should I take a probiotic with Crohn's?

Look for a strain with Crohn's-specific trial data, and expect a short list. Probiotic trials vary by strain and setting [12]. Do not assume a product studied in ulcerative colitis or pouchitis will help.

What vitamins should I test for with Crohn's?

Ask for 25(OH)D, B12, ferritin with CRP, serum zinc, and a CBC. A 2023 review found low levels of several nutrients in adults with Crohn's in remission [13]. Test first, then correct what is low.

Is fish oil good for Crohn's?

Not for maintenance. One small 1996 trial of a specific enteric-coated preparation found benefit [8], but two large trials of 4 g per day found none [9], and a Cochrane review called it probably ineffective [10].

Can diet alone treat Crohn's?

Diet is foundational, but "alone" is the wrong frame. EEN and CDED have strong remission data [1][2], and both are medical nutrition therapies run with a clinician. They do not replace prescribed medicine.

Are there supplements I should avoid?

Avoid high-dose iron without testing, unproven immune boosters, and turmeric with blood thinners, which can add to bleeding risk [19]. Avoid bulky fiber if you have a stricture. Ask your gastroenterologist before adding anything during a flare.

References

  1. Kaur K, Singh A, Kaur S, et al. Exclusive enteral nutrition for induction of remission in Crohn's disease in adults: a systematic review and meta-analysis of randomized trials and real-world studies. Indian Journal of Gastroenterology. 2026. PMID 42065851. https://pubmed.ncbi.nlm.nih.gov/42065851/
  2. Batra G, Shukla A, Chatterjee A, et al. Meta-analysis: Crohn's disease exclusion diet for induction and maintenance in Crohn's disease. Alimentary Pharmacology and Therapeutics. 2026. PMID 42437372. https://pubmed.ncbi.nlm.nih.gov/42437372/
  3. Jatkowska A, White B, Gkikas K, et al. Partial enteral nutrition in the management of Crohn's disease: a systematic review and meta-analysis. Journal of Crohn's and Colitis. 2025. PMID 39565924. https://pubmed.ncbi.nlm.nih.gov/39565924/
  4. Mohseni S, Tavakoli A, Ghazipoor H, et al. Curcumin for the clinical treatment of inflammatory bowel diseases: a systematic review and meta-analysis of placebo-controlled randomized clinical trials. Frontiers in Nutrition. 2025. PMID 40196017. https://pubmed.ncbi.nlm.nih.gov/40196017/
  5. Zeng L, Yang T, Yang K, et al. Curcumin and Curcuma longa extract in the treatment of 10 types of autoimmune diseases: a systematic review and meta-analysis of 31 randomized controlled trials. Frontiers in Immunology. 2022. PMID 35979355. https://pubmed.ncbi.nlm.nih.gov/35979355/
  6. Gerhardt H, Seifert F, Buvari P, Vogelsang H, Repges R. Therapy of active Crohn disease with Boswellia serrata extract H 15. Zeitschrift fur Gastroenterologie. 2001. PMID 11215357. https://pubmed.ncbi.nlm.nih.gov/11215357/
  7. Holtmeier W, Zeuzem S, Preiss J, et al. Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohn's disease: good safety profile but lack of efficacy. Inflammatory Bowel Diseases. 2011. PMID 20848527. https://pubmed.ncbi.nlm.nih.gov/20848527/
  8. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. New England Journal of Medicine. 1996. PMID 8628335. https://pubmed.ncbi.nlm.nih.gov/8628335/
  9. Feagan BG, Sandborn WJ, Mittmann U, et al. Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC randomized controlled trials. JAMA. 2008. PMID 18398081. https://pubmed.ncbi.nlm.nih.gov/18398081/
  10. Lev-Tzion R, Griffiths AM, Leder O, Turner D. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease. Cochrane Database of Systematic Reviews. 2014. PMID 24585498. https://pubmed.ncbi.nlm.nih.gov/24585498/
  11. Ge X, Liu H, Wu Y, et al. Parenteral n-3 polyunsaturated fatty acids supplementation improves postoperative recovery for patients with Crohn's disease after bowel resection: a randomized, unblinded controlled clinical trial. American Journal of Clinical Nutrition. 2024. PMID 38569774. https://pubmed.ncbi.nlm.nih.gov/38569774/
  12. Hijova E. Probiotics in IBD: evidence and perspectives on patient health and disease management. International Journal of Molecular Sciences. 2025. PMID 41009629. https://pubmed.ncbi.nlm.nih.gov/41009629/
  13. McDonnell M, Sartain S, Westoby C, Katarachia V, Wootton SA, Cummings JRF. Micronutrient status in adult Crohn's disease during clinical remission: a systematic review. Nutrients. 2023. PMID 38004171. https://pubmed.ncbi.nlm.nih.gov/38004171/
  14. O'Donnell JEM, Leach ST, Bowcock NL, et al. Daily vitamin D3 versus stoss vitamin D3 for correction of 25OHD deficiency in children with inflammatory bowel disease, a randomised controlled trial. Digestive Diseases and Sciences. 2025. PMID 40021606. https://pubmed.ncbi.nlm.nih.gov/40021606/
  15. Gordon M, Sinopoulou V, Iheozor-Ejiofor Z, et al. Interventions for treating iron deficiency anaemia in inflammatory bowel disease. Cochrane Database of Systematic Reviews. 2021. PMID 33471939. https://pubmed.ncbi.nlm.nih.gov/33471939/
  16. Nomura A, Otagiri S, Katsurada T, Tanaka S, Fujihata K, Sakamoto N. Association between zinc status and tight junction integrity and proinflammatory cytokine expression in Crohn's disease. JGH Open. 2026. PMID 42926740. https://pubmed.ncbi.nlm.nih.gov/42926740/
  17. De Conno B, Pesce M, Chiurazzi M, et al. Nutraceuticals and diet supplements in Crohn's disease: a general overview of the most promising approaches in the clinic. Foods. 2022. PMID 35407131. https://pubmed.ncbi.nlm.nih.gov/35407131/
  18. American College of Gastroenterology. ACG clinical guideline: management of Crohn's disease in adults. 2025. PMID 40701562. https://pubmed.ncbi.nlm.nih.gov/40701562/
  19. Dobre MZ, Virgolici B, Doicin IC, Virgolici H, Stanescu-Spinu II. Navigating the effects of anti-atherosclerotic supplements and acknowledging associated bleeding risks. International Journal of Molecular Sciences. 2025. PMID 41155474. https://pubmed.ncbi.nlm.nih.gov/41155474/

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.